DOXY Drug Patent Profile
✉ Email this page to a colleague
When do Doxy patents expire, and what generic alternatives are available?
Doxy is a drug marketed by Fresenius Kabi Usa, Teva, Par Pharm, Rachelle, Aiping Pharm Inc, Alembic, Apotex, Cosette, Dr Reddys, Dr Reddys Labs Sa, Impax Labs Inc, Lupin, Macleods Pharms Ltd, Prinston Inc, Rising, Sandoz Inc, Strides Pharma, Strides Pharma Intl, Sun Pharm Inds Ltd, Watson Labs, Zydus Pharms, Chartwell, Lupin Ltd, Hikma, Mylan Labs Ltd, Chartwell Rx, Heritage, Lannett Co Inc, Sun Pharm Industries, Pliva, Bausch, Actavis Labs Fl Inc, Ajanta Pharma Ltd, Amneal Pharms, Bionpharma, Changzhou Pharm, Halsey, Heather, Hikma Intl Pharms, Interpharm, Mutual Pharm, Nesher Pharms, Pvt Form, Ranbaxy, Superpharm, Warner Chilcott, Zhejiang Yongtai, Zydus Lifesciences, Amneal, Aspiro, Avet Lifesciences, Gland, Kindos, Ph Health, Precision Dose Inc, Slate Run Pharma, Steriscience, West-ward Pharms Int, Actavis Elizabeth, Aurobindo Pharma Usa, Acella, Amneal Pharms Co, Chartwell Molecular, Epic Pharma Llc, Heritage Pharma, Mylan, Novel Labs Inc, Oryza, Pharmobedient, Praxgen, Torrent, Copley Pharm, LNK, Perrigo, and Quantum Pharmics. and is included in one hundred and thirty-nine NDAs.
The generic ingredient in DOXY is doxylamine succinate; pyridoxine hydrochloride. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the doxylamine succinate; pyridoxine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxy
A generic version of DOXY was approved as doxylamine succinate; pyridoxine hydrochloride by ACTAVIS LABS FL INC on August 19th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOXY?
- What are the global sales for DOXY?
- What is Average Wholesale Price for DOXY?
Summary for DOXY
| US Patents: | 0 |
| Applicants: | 75 |
| NDAs: | 139 |
| Drug Prices: | Drug price information for DOXY |
| Drug Sales Revenues: | Drug sales revenues for DOXY |
| DailyMed Link: | DOXY at DailyMed |
US Patents and Regulatory Information for DOXY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma Intl | DOXYCYCLINE | doxycycline | TABLET;ORAL | 065070-002 | Dec 15, 2000 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 062392-001 | Mar 31, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Halsey | DOXYCYCLINE HYCLATE | doxycycline hyclate | CAPSULE;ORAL | 062119-001 | May 24, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | DOXYCYCLINE | doxycycline | CAPSULE;ORAL | 065041-001 | Apr 28, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz Inc | DOXYCYCLINE | doxycycline | CAPSULE;ORAL | 065032-002 | Jun 30, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lupin | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 208741-003 | Aug 11, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
